Science
New virtual screening strategy identifies existing drug that inhibits COVID-19 virus: In lab experiments, pralatrexate outperforms remdesivir against SARS-CoV-2 – Science Daily
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma,…
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat Covid-19. Haiping Zhang of the Shenzhen Institutes of Advanced Technology in Shenzhen, China, and colleagues present these findings in the open-access journal PLOS Computational Biology.With the Covid-19 pandemic causing illness and death worldwide, better treatments are urgently needed. One…
-
General15 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
General22 hours agoPolice offer ‘surrender plan’ to Dezi Freeman as fugitive avoids capture for another day
-
General21 hours agoGeelong Cats AFL star Bailey Smith details mental health battle during All-Australian speech
-
Noosa News12 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally